Your session is about to expire
← Back to Search
Myo-inositol, folic acid for Gestational Diabetes
N/A
Waitlist Available
Led By Amy M Valent, DO
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1,4,7,10
Awards & highlights
Study Summary
Myo-inositol has been shown to decrease the rate of diabetes in pregnancy in European studies. It is not known exactly how this occurs or what it does to the sugar when the supplement is taken. This study purpose is to look at the patient's sugar levels while taking the supplement to see if the overall levels of sugar go down. We hypothesize that in addition to sugar levels, other hormones influencing diabetes will be altered.
Eligible Conditions
- Gestational Diabetes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1,4,7,10
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1,4,7,10
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
overall mean glucose
Secondary outcome measures
metabolic differences
Other outcome measures
side effects
steady state
Trial Design
1Treatment groups
Experimental Treatment
Group I: Myo-inositol, folic acidExperimental Treatment3 Interventions
myo-inositol, oral, 2g, two times per day for 5 total days
folic acid, oral 200 micrograms, two times per day for 7 days
Continuous Glucose Monitoring Surveillance device for 7 days during study period
Capillary glucose monitoring 4 times per day
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Glucose monitoring
2019
N/A
~10
myo-inositol
2010
Completed Phase 3
~310
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
973 Previous Clinical Trials
7,385,772 Total Patients Enrolled
Duke UniversityOTHER
2,363 Previous Clinical Trials
3,420,466 Total Patients Enrolled
Washington University School of MedicineOTHER
1,935 Previous Clinical Trials
2,299,767 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger